Preeclampsia screening helps estimate the chance of developing high blood pressure-related pregnancy complications later in pregnancy. Uterine artery Doppler assesses blood flow resistance between the uterus and placenta, helping identify pregnancies that need closer follow-up.
Preeclampsia can affect the mother, placenta and baby. Some women develop severe disease early; some develop milder disease later. Screening helps separate routine-risk pregnancies from those that may need more careful blood pressure follow-up, fetal growth scans and Doppler surveillance.
Dr. Kunda Shahane interprets uterine artery Doppler along with maternal history, blood pressure, previous pregnancy history, diabetes, kidney disease, autoimmune disorders, twin pregnancy, IVF pregnancy and fetal growth risk.
Preeclampsia usually involves high blood pressure after mid-pregnancy and may affect organs such as kidneys, liver, brain, blood clotting system and the placenta.
Blood pressure trend is central. Screening does not replace regular BP checks during pregnancy.
Measures blood flow resistance in the arteries supplying the placenta.
Placental insufficiency can be associated with fetal growth restriction and low amniotic fluid.
Higher risk may need growth scan, Doppler, NST/BPP and obstetric review at planned intervals.
A low-risk result does not guarantee that preeclampsia will not occur. A high-risk result does not mean it will definitely occur. Screening helps decide how much surveillance is appropriate.
The exact protocol depends on gestational age, available tests and the clinical situation.
| Screening component | What is assessed | Why it matters | Possible follow-up if high risk |
|---|---|---|---|
| Maternal history | Previous preeclampsia, chronic hypertension, kidney disease, autoimmune disease, diabetes, IVF, twin pregnancy, age and BMI. | Some risk factors are known before any scan and strongly influence risk assessment. | Obstetric risk review |
| Mean arterial pressure | Blood pressure readings are used to assess early maternal vascular risk. | High or rising BP may signal need for closer maternal follow-up. | BP monitoring |
| Uterine artery Doppler | Uterine artery pulsatility index and flow pattern on both sides. | High resistance may suggest increased risk of placental insufficiency, preeclampsia or fetal growth restriction. | Repeat Doppler Growth scan |
| Placental biomarkers when available | Some protocols include blood tests such as PlGF and/or PAPP-A. | Biochemical markers may improve risk prediction when combined with Doppler and maternal factors. | Combined risk report |
| NT / first-trimester scan correlation | Pregnancy dating, fetal viability, early anatomy and first-trimester screening results. | Correct dating is essential for accurate risk calculation and later growth assessment. | Planned scan calendar |
| Risk category | Low-risk, increased-risk or high-risk category depending on protocol and findings. | Helps guide counselling, aspirin discussion with obstetrician, BP follow-up and fetal surveillance. | High-risk pregnancy follow-up |
International guidelines support low-dose aspirin in selected high-risk pregnancies, ideally started early when indicated. However, aspirin should be started only after discussion with your obstetrician or fetal medicine specialist, because dose, timing and suitability depend on individual history.
The uterine arteries carry blood from the mother to the uterus and placenta. In early pregnancy, the placenta should develop a low-resistance blood flow system. Higher resistance on uterine artery Doppler may suggest that placental development needs closer monitoring.
This is why uterine artery Doppler is useful in preeclampsia risk assessment and in pregnancies at risk of fetal growth restriction.
A prior pregnancy complicated by preeclampsia, fetal growth restriction or early delivery may need early risk review.
Pre-existing high blood pressure increases risk and usually needs close maternal and fetal surveillance.
Kidney disease, lupus, antiphospholipid syndrome or similar conditions can increase pregnancy vascular risk.
Pre-existing diabetes or high-risk metabolic history may require early maternal-fetal planning.
Twin pregnancy and IVF pregnancies may have higher risk and need structured follow-up.
Age, first pregnancy and multiple moderate risk factors may influence screening and prevention planning.
Dr. Kunda explains that increased risk is not a diagnosis. It means the pregnancy needs closer watch than routine low-risk care.
Preventive measures, including low-dose aspirin where appropriate, are discussed with the treating obstetrician based on individual suitability.
BP checks, urine protein testing, blood tests and symptom review may be planned by the obstetrician.
Growth scans assess fetal weight, abdominal circumference, amniotic fluid and growth trend.
Umbilical artery, MCA Doppler, BPP or NST may be used later if fetal growth, fluid or maternal condition raises concern.
Persistent severe headache, blurring of vision, flashing lights or confusion needs urgent medical assessment.
Pain below the ribs, sudden swelling of face/hands, breathlessness or feeling very unwell should not be ignored.
Clearly reduced fetal movements need urgent obstetric review or nearest hospital assessment, not only routine appointment.
If you have severe symptoms, very high BP, seizures, bleeding, severe pain or markedly reduced fetal movements, contact your obstetrician or nearest hospital immediately. Do not wait for a routine scan slot.
Bring records of preeclampsia, high BP, early delivery, fetal growth restriction, miscarriage or stillbirth if any.
Carry BP records, diabetes records, kidney reports, autoimmune tests, medication list and IVF details if applicable.
Bring dating scan, NT scan, blood tests, anomaly scan if already done, and any previous Doppler or growth reports.
“Preeclampsia screening is valuable because it allows us to identify pregnancies that need closer observation before complications appear. Uterine artery Doppler gives information about placental blood flow, but it must always be interpreted with maternal history, blood pressure, fetal growth and the treating obstetrician’s plan.”
It is a risk assessment that estimates the chance of preeclampsia later in pregnancy. It may include maternal history, blood pressure, uterine artery Doppler and selected blood markers.
It is often done in the first trimester around 11–14 weeks as part of risk assessment, and may also be reassessed later when clinically indicated.
No. It suggests increased risk of placental insufficiency-related complications. It does not confirm that preeclampsia will definitely occur.
Risk can sometimes be reduced in selected high-risk pregnancies with timely obstetric planning, including low-dose aspirin when suitable. Do not self-start medicines; discuss with your obstetrician.
No. It is a non-invasive ultrasound Doppler assessment and does not involve injection, needle or surgery.
High risk means closer monitoring is needed. Your doctor may advise BP follow-up, urine/blood tests, growth scans, Doppler, NST/BPP and prevention planning.
Yes. No screening test is perfect. All pregnant patients still need routine BP checks, symptom awareness and obstetric follow-up.
No. Preeclampsia screening estimates risk, while growth scan later checks fetal size, amniotic fluid and fetal wellbeing. Both may be linked in high-risk care.
Book a preeclampsia risk assessment and uterine artery Doppler appointment with Dr. Kunda Shahane at Mayflower Fetal Medicine & High-Risk Pregnancy Centre, Dhantoli, Nagpur. Carry your BP records, previous pregnancy history and current pregnancy reports.
Mayflower Fetal Medicine & High-Risk Pregnancy Centre, Dhantoli, Nagpur, provides fetal ultrasound, prenatal diagnosis, fetal echocardiography, Doppler studies, genetic counseling and high-risk pregnancy care under Dr. Kunda Shahane.

Fetal Echocardiography: Detecting Heart Defects before Birth…

High-Risk Pregnancy: How Fetal Medicine Supports Moms…
Surdham Complex, Behind Silver Palace Building, 2nd Lane from Panchsheel Sq., Opp. Yashwant Stadium, Dhantoli Nagpur - 440012
07126692706
whatsapp 8087471244
